Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 8726 - 8750 of 11500 in total
Experimental
Matched Name: … P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate …
Matched Iupac: … -2-yl]-5-methyl-2-oxo-1,2-dihydropyrimidin-4-olate ... }oxy)(oxido)phosphoryl]oxy}(hydroxy)phosphoryl phosphonato)oxy](oxido)phosphoryl}oxy)methyl]-4-azidooxolan ... 1-[(2R,4S,5S)-5-[({[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphonato …
Methapyrilene, formerly marketed in many drug products, was shown to be a potent carcinogen. Manufacturers voluntarily withdrew methapyriline drug products from the market in May and June 1979.
Withdrawn
Matched Synonyms: … 2-[[2-(Dimethylamino)ethyl]-2-thenylamino]pyridine ... N,N-dimethyl-N'-pyrid-2-yl-N'-2-thenylethylenediamine ... N,N-dimethyl-N'-pyridin-2-yl-N'-(2-thienylmethyl)ethane-1,2-diamine …
Matched Iupac: … N-[2-(dimethylamino)ethyl]-N-[(thiophen-2-yl)methyl]pyridin-2-amine …
Investigational
Experimental
Matched Name: … N-methyl-1-(2-thiophen-2-ylphenyl)methanamine …
Matched Iupac: … methyl({[2-(thiophen-2-yl)phenyl]methyl})amine …
Experimental
Matched Name: … 2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE …
Matched Iupac: … 2-(2-methylphenyl)-1H-indole-6-carboximidamide …
Barnidipine is a long-acting novel calcium antagonist that belongs to the dihydropyridine (DHP) group of calcium channel blockers. Used in the treatment of hypertension, barnidipine displays high affinity for the calcium channels of the smooth muscle cells in the vascular wall and selectivity against cardiovascular L-type calcium channels . Barnidipine...
Experimental
Matched Iupac: … 3-(3S)-1-benzylpyrrolidin-3-yl 5-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate …
Matched Description: … The active component is composed of a single optical isomer (*3'S, 4S* configuration), which is the most ... hypertension, the antihypertensive response from barnidipine treatment was maintained after a 1-year and 2- …
Investigational
Experimental
Matched Iupac: … (2R,3R,4R,5R)-2,5-bis(benzyloxy)-3,4-dihydroxy-N,N'-bis[(1S)-2-methyl-1-{[(pyridin-2-yl)methyl]carbamoyl …
Experimental
Matched Iupac: … (2S)-2-amino-3-(3,5-dibromo-4-hydroxyphenyl)propanoic acid …
Investigational
Matched Synonyms: … Acetamide, n-((2,5-dimethoxyphenyl)methyl)-2-(fluoro-18f)-n-(2-phenoxyphenyl)- …
Matched Iupac: … N-[(2,5-dimethoxyphenyl)methyl]-2-(¹⁸F)fluoro-N-(2-phenoxyphenyl)acetamide …
Experimental
Matched Iupac: … (5Z)-7-{2-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopent-1-en-1-yl}hept-5-enoic acid …
Experimental
Matched Name: … 2-Dehydropantoate …
Matched Iupac: … 4-hydroxy-3,3-dimethyl-2-oxobutanoic acid …
LY2181308 is investigated in clinical trials for treating solid tumors. LY2181308 is a solid. LY2181308 is directed against a molecular target called survivin. LY2181308 is known to target baculoviral IAP repeat-containing protein 5. LY2181308 is an anti-sense oligonucleotide that potently downregulated survivin expression in human cancer cells derived from lung,...
Investigational
LY2275796 is a second-generation antisense anti-cancer drug candidate for clinical development. LY2275796 targets eukaryotic initiation factor- 4E (eIF-4E), a protein involved in the translation of key growth and survival factors that drive tumor progression, angiogenesis and metastases.
Investigational
LY2828360 is under investigation in clinical trial NCT01319929 (A Study of LY2828360 in Patients With Osteoarthritic Knee Pain).
Investigational
Matched Iupac: … 8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(oxan-4-yl)-9H-purine …
Matched Categories: … Heterocyclic Compounds, 2-Ring …
Investigational
Kisspeptin-10 is under investigation in clinical trial NCT03771326 (KP-10 and Insulin Secretion in Men).
Investigational
Experimental
Matched Name: … 3-Amino-6-Hydroxy-Tyrosine …
Matched Iupac: … (2S)-2-amino-3-(5-amino-2,4-dihydroxyphenyl)propanoic acid …
Experimental
Matched Synonyms: … 1-ethoxy-2-(2-methoxyethoxy)ethane …
Matched Iupac: … 1-ethoxy-2-(2-methoxyethoxy)ethane …
Experimental
Matched Name: … N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide …
Matched Iupac: … N2-[(thiophen-2-yl)methyl]thiophene-2,5-disulfonamide …
Experimental
Matched Iupac: … (2R)-3,3-dimethylbutan-2-yl methylphosphinate …
Experimental
Matched Name: … 2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One …
Matched Iupac: … 2-amino-7-{2-[(1,3-dihydroxypropan-2-yl)amino]ethyl}-6,7-dihydro-1H-purin-6-one …
Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).
Investigational
Displaying drugs 8726 - 8750 of 11500 in total